ATRA (ATRA) Stock Price & Analysis
ATRA (ATRA) rose 2.41% to USD 9.76 as of September 8, 2026 at 06:20 UTC, according to Nexqual real-time market data.
ATRA last closed at USD 9.76; the session ranged USD 9.25–9.94 on volume of 135,655 shares. Market capitalization is —, with a 52-week range of USD 3.92–19.15 (NMS). Source: Nexqual, September 8, 2026 at 06:20 UTC.
Key Statistics (as of September 8, 2026 at 06:20 UTC)
| Price | USD 9.76 |
|---|---|
| Change | ▲ 2.41% (up) |
| Previous Close | USD 9.76 |
| Open | USD 9.76 |
| Day Range | USD 9.25 – 9.94 |
| 52-Week Range | USD 3.92 – 19.15 |
| Volume | 135,655 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (ATRA)
Nexqual's technical model rates ATRA "BUY" based on 5 bullish and 1 bearish signals across 128 daily candles, as of September 8, 2026 at 06:20 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 59.19 (neutral) |
| vs SMA50 | Above (USD 9.12) |
| MACD | 0.17 (positive) |
From ATRA's Latest SEC 10-K Filing (filed 2026-03-16)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ALLO | Allogene Therapeutics, Inc. | USD 1.97 | ▼ 0.51% |
| KYNB | Kyntra Bio, Inc. | USD 8.55 | ▲ 0.23% |
| MGNX | MacroGenics, Inc. | USD 4.4 | ▲ 1.85% |
| CTMX | CytomX Therapeutics, Inc. | USD 3.71 | ▼ 0.27% |
| ANAB | AnaptysBio, Inc. | USD 56.8 | ▲ 1.72% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 06:20 UTC. This page is informational and not investment advice.